Investor Relations


SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation January, 2015.

Recent Releases

Jan 28, 2015
Correction: SciClone to Present at BIO CEO & Investor Conference on February 9, 2015 at 11 am ET

Jan 28, 2015
SciClone to Present at BIO CEO & Investor Conference on February 9, 2015

View all releases »

Events & Presentations

Feb 9, 2015 at 11:00 AM ET
BIO CEO & Investor Conference

Nov 19, 2014 at 4:20 PM UK
Jefferies Global Healthcare Conference

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 7.65
Change: + 0.25
Day High: 7.66
Day Low: 7.34
Volume: 140,600
Delayed at least 20 minutes.
Provided by eSignal.